Foresite Capital Management III’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-998,278
| Closed | -$5.11M | – | 7 |
|
2021
Q3 | $5.11M | Hold |
998,278
| – | – | 7.09% | 5 |
|
2021
Q2 | $8.3M | Hold |
998,278
| – | – | 8.79% | 4 |
|
2021
Q1 | $8.7M | Hold |
998,278
| – | – | 7.64% | 6 |
|
2020
Q4 | $10.8M | Hold |
998,278
| – | – | 12.6% | 5 |
|
2020
Q3 | $11.9M | Hold |
998,278
| – | – | 8.87% | 5 |
|
2020
Q2 | $16M | Buy |
998,278
+284,466
| +40% | +$4.57M | 14.26% | 4 |
|
2020
Q1 | $11.1M | Buy |
713,812
+26,385
| +4% | +$409K | 17.63% | 2 |
|
2019
Q4 | $16.9M | Sell |
687,427
-310,851
| -31% | -$7.65M | 9.48% | 4 |
|
2019
Q3 | $10.3M | Hold |
998,278
| – | – | 3.93% | 8 |
|
2019
Q2 | $12.5M | Hold |
998,278
| – | – | 4.11% | 8 |
|
2019
Q1 | $12.4M | Buy |
998,278
+63
| +0% | +$781 | 3.22% | 10 |
|
2018
Q4 | $6.15M | Buy |
998,215
+80,500
| +9% | +$496K | 2.02% | 13 |
|
2018
Q3 | $9.73M | Sell |
917,715
-22,970
| -2% | -$243K | 2.15% | 14 |
|
2018
Q2 | $12.7M | Sell |
940,685
-57,593
| -6% | -$780K | 2.74% | 11 |
|
2018
Q1 | $17.7M | Hold |
998,278
| – | – | 3.86% | 11 |
|
2017
Q4 | $12.5M | Buy |
998,278
+148,585
| +17% | +$1.86M | 3.52% | 9 |
|
2017
Q3 | $16.2M | Buy |
849,693
+50,330
| +6% | +$959K | 4.46% | 8 |
|
2017
Q2 | $12.1M | Buy |
799,363
+117,441
| +17% | +$1.77M | 3.94% | 8 |
|
2017
Q1 | $11.7M | Buy |
681,922
+76,683
| +13% | +$1.32M | 4.49% | 6 |
|
2016
Q4 | $7.32M | Sell |
605,239
-6,538
| -1% | -$79.1K | 3.18% | 10 |
|
2016
Q3 | $6.02M | Buy |
611,777
+100,000
| +20% | +$984K | 2.81% | 10 |
|
2016
Q2 | $5.24M | Buy |
511,777
+35,000
| +7% | +$358K | 3.6% | 7 |
|
2016
Q1 | $5.78M | Buy |
476,777
+15,126
| +3% | +$183K | 4.47% | 6 |
|
2015
Q4 | $7.4M | Buy |
+461,651
| New | +$7.4M | 6.56% | 4 |
|